These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25453988)

  • 1. A genetic basis for coronary artery disease.
    Roberts R
    Trends Cardiovasc Med; 2015 Apr; 25(3):171-8. PubMed ID: 25453988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics-Current and Future Role in the Prevention and Management of Coronary Artery Disease.
    Roberts R
    Curr Atheroscler Rep; 2016 Dec; 18(12):78. PubMed ID: 27815829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease.
    Zhang Y; Xu RX; Li S; Zhu CG; Guo YL; Sun J; Li JJ
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):426-33. PubMed ID: 25770756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.
    Page MM; Stefanutti C; Sniderman A; Watts GF
    Clin Sci (Lond); 2015 Jul; 129(1):63-79. PubMed ID: 25881720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PCSK9: a novel approach for the treatment of dyslipidemia.
    Stawowy P; Just IA; Kaschina E
    Coron Artery Dis; 2014 Jun; 25(4):353-9. PubMed ID: 24667128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What promise does PCSK9 hold?
    Kastelein JJ; Fouchier SW; Defesche JC
    J Am Coll Cardiol; 2005 May; 45(10):1620-1. PubMed ID: 15893177
    [No Abstract]   [Full Text] [Related]  

  • 7. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
    Chen SN; Ballantyne CM; Gotto AM; Tan Y; Willerson JT; Marian AJ
    J Am Coll Cardiol; 2005 May; 45(10):1611-9. PubMed ID: 15893176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
    Sahebkar A; Watts GF
    Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of coronary artery disease in the 21st century.
    Roberts R; Stewart AF
    Clin Cardiol; 2012 Sep; 35(9):536-40. PubMed ID: 22588700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
    Li S; Xu RX; Guo YL; Zhang Y; Zhu CG; Sun J; Li JJ
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):411-7. PubMed ID: 25466598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and low-frequency genetic variants in the PCSK9 locus influence circulating PCSK9 levels.
    Chernogubova E; Strawbridge R; Mahdessian H; Mälarstig A; Krapivner S; Gigante B; Hellénius ML; de Faire U; Franco-Cereceda A; Syvänen AC; Troutt JS; Konrad RJ; Eriksson P; Hamsten A; van 't Hooft FM
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1526-34. PubMed ID: 22460556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Li S; Zhang Y; Li XL; Guo YL; Zhu CG; Li JJ
    Lipids Health Dis; 2014 Dec; 13():188. PubMed ID: 25496400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.
    Tarasov K; Ekroos K; Suoniemi M; Kauhanen D; Sylvänne T; Hurme R; Gouni-Berthold I; Berthold HK; Kleber ME; Laaksonen R; März W
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E45-52. PubMed ID: 24243630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study.
    Brouwers MC; Troutt JS; van Greevenbroek MM; Ferreira I; Feskens EJ; van der Kallen CJ; Schaper NC; Schalkwijk CG; Konrad RJ; Stehouwer CD
    Atherosclerosis; 2011 Jul; 217(1):263-7. PubMed ID: 21497351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetics of coronary artery disease.
    Roberts R; Stewart AF
    Curr Opin Cardiol; 2012 May; 27(3):221-7. PubMed ID: 22382499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to myocardial infarction and coronary artery disease.
    Topol EJ; Smith J; Plow EF; Wang QK
    Hum Mol Genet; 2006 Oct; 15 Spec No 2():R117-23. PubMed ID: 16987874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes and coronary artery disease: where are we?
    Roberts R; Stewart AF
    J Am Coll Cardiol; 2012 Oct; 60(18):1715-21. PubMed ID: 23040572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease.
    Helgadottir A; Gretarsdottir S; Thorleifsson G; Hjartarson E; Sigurdsson A; Magnusdottir A; Jonasdottir A; Kristjansson H; Sulem P; Oddsson A; Sveinbjornsson G; Steinthorsdottir V; Rafnar T; Masson G; Jonsdottir I; Olafsson I; Eyjolfsson GI; Sigurdardottir O; Daneshpour MS; Khalili D; Azizi F; Swinkels DW; Kiemeney L; Quyyumi AA; Levey AI; Patel RS; Hayek SS; Gudmundsdottir IJ; Thorgeirsson G; Thorsteinsdottir U; Gudbjartsson DF; Holm H; Stefansson K
    Nat Genet; 2016 Jun; 48(6):634-9. PubMed ID: 27135400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ApoCIII: the next PCSK9?
    Bernelot Moens SJ; van Capelleveen JC; Stroes ES
    Curr Opin Lipidol; 2014 Dec; 25(6):418-22. PubMed ID: 25255477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.